How to Reconstitute Retatrutide: A Step-by-Step Research Guide | Peptides New Zealand

How to Reconstitute Retatrutide: A Step-by-Step Research Guide

Retatrutide is supplied as a lyophilized (freeze-dried) powder. Before it can be used in research, it needs to be reconstituted — that is, dissolved back into a liquid solution. This process is straightforward but requires care to preserve the peptide's integrity and maintain sterility.

This guide walks through the reconstitution process in detail.

What You'll Need

Before starting, make sure you have the following equipment on hand:

• Retatrutide lyophilized powder (stored correctly at -20°C prior to use)

• Bacteriostatic water (the standard solvent for peptide reconstitution)

• Insulin syringes or appropriate low-dead-volume syringes

• Alcohol swabs (70% isopropyl alcohol)

• A clean, sterile work surface

Why bacteriostatic water? Bacteriostatic water contains a small amount of benzyl alcohol (0.9%), which inhibits bacterial growth and extends the usable life of your reconstituted solution. Sterile water can be used but results in a shorter stable period.

Step 1: Bring the Vial to Room Temperature

Remove your retatrutide vial from the freezer and allow it to sit at room temperature for 15–30 minutes before opening. This prevents condensation from forming inside the vial, which could introduce moisture at an uncontrolled rate and affect the powder.

Do not shake the vial or expose it to heat to speed up this process.

Step 2: Clean All Surfaces and Stoppers

Wipe the rubber stopper of your retatrutide vial and your bacteriostatic water vial with a fresh alcohol swab. Allow the alcohol to dry completely (around 30 seconds) before proceeding. This step is critical for maintaining sterility throughout the process.

Step 3: Draw Up Your Bacteriostatic Water

The volume of bacteriostatic water you add determines the concentration of your final solution. A common approach for research purposes is to add 1–2 mL of bacteriostatic water to a 10 mg vial, though the specific volume depends on the concentration needed for your research protocol.

Draw up your chosen volume of bacteriostatic water using a clean syringe.

Step 4: Inject the Water Slowly

This is the most important step. Insert your syringe through the rubber stopper at an angle and direct the stream of water down the inside wall of the vial — not directly onto the powder cake.

Inject slowly and steadily. Forcing water directly onto the peptide powder at high pressure can cause denaturation (structural damage to the peptide). Let it run gently down the side.

Step 5: Do Not Shake — Swirl Gently

Once the water has been added, the powder should begin dissolving. Do not shake the vial. Instead, gently swirl or roll it between your palms. The solution should become clear within a few minutes.

If there is any visible cloudiness, particulate matter, or if the solution does not become clear after gentle swirling, do not use it.

Step 6: Storage After Reconstitution

Once reconstituted, retatrutide solution should be stored at 4°C (standard laboratory refrigerator temperature). It should not be refrozen after reconstitution.

Use within an appropriate timeframe as per your research protocol — typically within 4 weeks when stored properly with bacteriostatic water, though this may vary depending on storage conditions.

Label your vial clearly with the date of reconstitution and the concentration.

Calculating Your Concentration

If you add 1 mL of bacteriostatic water to a 10 mg vial, your concentration is 10 mg/mL. If you add 2 mL, your concentration is 5 mg/mL. Having a clear record of your concentration is essential for accurate dosing in any research protocol.

Summary Checklist

• Allow vial to reach room temperature before opening

• Clean all stoppers with alcohol swabs

• Inject water slowly down the vial wall — not onto the powder directly

• Swirl gently — never shake

• Store reconstituted solution at 4°C

• Label with date and concentration

• Use within your protocol's recommended timeframe

This guide is intended for research purposes only. Retatrutide is not approved for human or veterinary use. All research should be conducted in appropriate settings by qualified professionals.